Antigenix Therapeutics, Inc.
CIK 2073993 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Antigenix Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Oct 24, 2025 | D | 0002073993-25-000001 |